NSF award 2528385 · Cleaved Diagnostic Corporation
STTR Phase I: A Novel Iothermal CRISPR-Cas12a Platform for the Detection of Viruses
Final report due
28 January 2027
in 102 days · The award ends on 30 September 2026.
GrantClerk is a private service. We are not NSF or any government agency.
Dates this award owes
NSF emails you about this too.
- Final report due28 Jan 2027in 102 days
award ending 2026-09-30 · Research.gov
- Project outcomes report due28 Jan 2027in 102 days
award ending 2026-09-30 · Research.gov
- Award is closed out28 Jan 2027in 102 days
award ending 2026-09-30 · Research.gov
Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.
How we got this date
- NSF lists this award's end date as 30 September 2026.
- NSF rules say the final report is due no later than 120 days after that.
- So the final report is due by 28 January 2027.
Get a note before each report date
Add this award to your desk. We email you before each date and keep the dates in one place.
Renews each year until you cancel. Cancel any time from your account.
Award card
- Award number
- 2528385
- Period of support
- 1 Oct 2025 – 30 Sep 2026
- Amount
- $305,000
- Awardee
- Cleaved Diagnostic Corporation, NEW Orleans, LA
- Program
- STTR Phase I
- Directorate
- TIP
Abstract
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is the creation of a reliable, highly sensitive, cost-effective, and easy-to-implement congenital cytomegalovirus (cCMV) screening that can be run with other newborn screening tests. cCMV affects about 25,000 babies born in the U.S. each year with moderate to severe long-term impairment (hearing loss and delayed…
Is this right?
We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.